Back to Menu
Ovarian Cancer Treatment Modalities
Main treatment approaches for ovarian cancer
1.Comprehensive surgical staging: The standard procedure for early-stage ovarian cancer, enabling accurate staging through complete resection of visible lesions and required staging components.
2.Cytoreductive surgery: Aims to achieve R0 resection whenever feasible and is a key determinant of prognosis in advanced disease.
3.Hyperthermic intraperitoneal chemotherapy (HIPEC): Applicable to selected patients with advanced disease; when combined with surgery, it can significantly prolong survival.
4.Chemotherapy: Typically platinum- and paclitaxel-based, with multiple strategies selected according to disease status.
5.Targeted therapy: PARP inhibitors show substantial benefit in patients with BRCA mutations and are commonly used as maintenance therapy.
6.Immunotherapy: Immune checkpoint inhibitors activate the host immune system to attack tumor cells.
7.Minimally invasive surgery: Laparoscopic surgery is associated with less trauma and faster recovery, and indications should be strictly selected.
8.Radiotherapy: Stereotactic radiotherapy provides an effective local control option for recurrent lesions.
9.Supportive care: Delivered throughout the entire treatment course to relieve symptoms and improve quality of life.
10.Fertility preservation: For carefully selected young patients with early-stage disease, fertility-sparing approaches may be considered.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes the importance of early diagnosis of ovarian cancer. Prognosis can be improved through multidisciplinary comprehensive treatment and emerging approaches such as targeted therapy and several types of immunotherapy. Women should strengthen awareness, undergo regular examinations, and seek timely medical attention when needed.
Ovarian Cancer Treatment Modalities
Main treatment approaches for ovarian cancer
1.Comprehensive surgical staging: The standard procedure for early-stage ovarian cancer, enabling accurate staging through complete resection of visible lesions and required staging components.
2.Cytoreductive surgery: Aims to achieve R0 resection whenever feasible and is a key determinant of prognosis in advanced disease.
3.Hyperthermic intraperitoneal chemotherapy (HIPEC): Applicable to selected patients with advanced disease; when combined with surgery, it can significantly prolong survival.
4.Chemotherapy: Typically platinum- and paclitaxel-based, with multiple strategies selected according to disease status.
5.Targeted therapy: PARP inhibitors show substantial benefit in patients with BRCA mutations and are commonly used as maintenance therapy.
6.Immunotherapy: Immune checkpoint inhibitors activate the host immune system to attack tumor cells.
7.Minimally invasive surgery: Laparoscopic surgery is associated with less trauma and faster recovery, and indications should be strictly selected.
8.Radiotherapy: Stereotactic radiotherapy provides an effective local control option for recurrent lesions.
9.Supportive care: Delivered throughout the entire treatment course to relieve symptoms and improve quality of life.
10.Fertility preservation: For carefully selected young patients with early-stage disease, fertility-sparing approaches may be considered.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes the importance of early diagnosis of ovarian cancer. Prognosis can be improved through multidisciplinary comprehensive treatment and emerging approaches such as targeted therapy and several types of immunotherapy. Women should strengthen awareness, undergo regular examinations, and seek timely medical attention when needed.